Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 48 articles: HTML format

Single Articles

June 2021
1. ABE SK, Narita S, Saito E, Sawada N, et al
   Body mass index, height, weight change, and subsequent lung cancer risk: the Japan Public Health Center-based Prospective Study.
   Cancer Epidemiol Biomarkers Prev. 2021 Jun 25. pii: 1055-9965.EPI-21-0195.
   PubMed     Abstract available
   
   
   
2. WOOD AM, Jonsson H, Nagel G, Haggstrom C, et al
   The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking.
   Cancer Epidemiol Biomarkers Prev. 2021 Jun 22. pii: 1055-9965.EPI-21-0058.
   PubMed     Abstract available
   
   
   
3. ZHANG EW, Shepard JO, Kuo A, Chintanapakdee W, et al
   Characteristics and outcomes of lung cancers detected on low-dose lung cancer screening CT.
   Cancer Epidemiol Biomarkers Prev. 2021 Jun 9. pii: 1055-9965.EPI-20-1847.
   PubMed     Abstract available
   
   
   
4. ERHUNMWUNSEE L, Wing SE, Shen J, Hu H, et al
   The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2021 Jun 4. pii: 1055-9965.EPI-20-1555.
   PubMed     Abstract available
   
   
   May 2021
5. DEROUEN MC, Thompson CA, Canchola AJ, Jin A, et al
   Integrating electronic health record, cancer registry, and geospatial data to study lung cancer in Asian American, Native Hawaiian and Pacific Islander ethnic groups.
   Cancer Epidemiol Biomarkers Prev. 2021 May 17. pii: 1055-9965.EPI-21-0019.
   PubMed     Abstract available
   
   
   April 2021
6. WILUNDA C, Sawada N, Yamaji T, Iwasaki M, et al
   Reproductive factors and lung cancer risk among never-smoking Japanese women with 21 years of follow-up: a cohort study.
   Cancer Epidemiol Biomarkers Prev. 2021 Apr 7. pii: 1055-9965.EPI-20-1399.
   PubMed     Abstract available
   
   
   March 2021
7. BYUN J, Han Y, Ostrom QT, Edelson J, et al
   The shared genetic architectures between lung cancer and multiple polygenic phenotypes in genome-wide association studies.
   Cancer Epidemiol Biomarkers Prev. 2021 Mar 26. pii: 1055-9965.EPI-20-1635.
   PubMed     Abstract available
   
   
   November 2020
8. HERMAN JG, Farooq M
   Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a focus on Changes in DNA Methylation.
   Cancer Epidemiol Biomarkers Prev. 2020 Nov 4. pii: 1055-9965.EPI-20-0704.
   PubMed     Abstract available
   
   
   October 2020
9. OSTRIN EJ, Sidransky D, Spira A, Hanash SM, et al
   Biomarkers for lung cancer screening and detection.
   Cancer Epidemiol Biomarkers Prev. 2020 Oct 22. pii: 1055-9965.EPI-20-0865.
   PubMed     Abstract available
   
   
   September 2020
10. WAH W, Stirling RG, Ahern S, Earnest A, et al
    ASSOCIATION BETWEEN RECEIPT OF GUIDELINE-CONCORDANT LUNG CANCER TREATMENT AND INDIVIDUAL- AND AREA-LEVEL FACTORS: A SPATIO-TEMPORAL ANALYSIS.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 18. pii: 1055-9965.EPI-20-0709.
    PubMed     Abstract available
    
    
    August 2020
11. LIM RJ, Liu B, Krysan K, Dubinett SM, et al
    Lung Cancer and Immunity Markers.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 20. pii: 1055-9965.EPI-20-0716.
    PubMed     Abstract available
    
    
    
12. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    PubMed     Abstract available
    
    
    July 2020
13. BRHANE Y, Yang P, Christiani DC, Liu G, et al
    Genetic determinants of lung cancer prognosis in never smokers: A pooled analysis in the International Lung Cancer Consortium.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 22. pii: 1055-9965.EPI-20-0248.
    PubMed     Abstract available
    
    
    June 2020
14. ZHAO YC, Tang D, Yang S, Liu H, et al
    Novel variants of ELP2 and PIAS1 in the interferon gamma signaling pathway are associated with non-small cell lung cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2020 Jun 3. pii: 1055-9965.EPI-19-1450.
    PubMed     Abstract available
    
    
    April 2020
15. WANG Y, Gorlova OY, Gorlov IP, Zhu M, et al
    Association analysis of driver-gene related genetic variants identified novel lung cancer susceptibility loci with 20,871 lung cancer cases and 15,971 controls.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1085.
    PubMed     Abstract available
    
    
    
16. PAL CHOUDHURY P, Chaturvedi AK, Chatterjee N
    Evaluating Discrimination of a Lung Cancer Risk Prediction Model Using Partial Risk-score in a Two-phase Study.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1574.
    PubMed     Abstract available
    
    
    
17. WEI Q, Deng W, Liu H, Luo S, et al
    APOB genotypes and CDH13 haplotypes in the cholesterol-related pathway genes predict non-small cell lung cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 1. pii: 1055-9965.EPI-19-1262.
    PubMed     Abstract available
    
    
    January 2020
18. WILLIAMS CD, Alpert N, Redding TS 4th, Bullard AJ, et al
    Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Cancer Epidemiol Biomarkers Prev. 2020;29:112-118.
    PubMed     Abstract available
    
    
    December 2019
19. CHIEN LH, Chen CH, Chen TY, Chang GC, et al
    Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 17. pii: 1055-9965.EPI-19-1221.
    PubMed     Abstract available
    
    
    
20. MUSOLF AM, Moiz BA, Sun H, Pikielny CW, et al
    Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p and 4q.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 11. pii: 1055-9965.EPI-19-0887.
    PubMed     Abstract available
    
    
    November 2019
21. THOMAS CE, Wang R, Adams-Haduch J, Murphy SE, et al
    Urinary cotinine is as good a biomarker as serum cotinine for cigarette smoking exposure and lung cancer risk prediction.
    Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: 1055-9965.EPI-19-0653.
    PubMed     Abstract available
    
    
    October 2019
22. UDUMYAN R, Montgomery S, Fang F, Valdimarsdottir U, et al
    Beta-blocker use and lung cancer mortality in a nationwide cohort study of patients with primary non-small cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Oct 22. pii: 1055-9965.EPI-19-0710.
    PubMed     Abstract available
    
    
    
23. SCHABATH MB, Cote ML
    Cancer Progress and Priorities: Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019;28:1563-1579.
    PubMed    
    
    
    September 2019
24. D'ANTONA P, Cattoni M, Dominioni L, Poli A, et al
    Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0626.
    PubMed     Abstract available
    
    
    July 2019
25. KACHURI L, Helby J, Bojesen SE, Christiani DC, et al
    Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019;28:1228-1237.
    PubMed     Abstract available
    
    
    April 2019
26. HUO J, Hong YR, Bian J, Guo Y, et al
    Low Rates of Patient-Reported Physician-Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0629.
    PubMed     Abstract available
    
    
    
27. GRAFETSTATTER M, Husing A, Gonzalez Maldonado S, Sookthai D, et al
    Plasma Fibrinogen and sP-Selectin are associated with the risk of lung cancer in a prospective study.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1285.
    PubMed     Abstract available
    
    
    March 2019
28. JONES CC, Bradford Y, Amos CI, Blot WJ, et al
    Cross-cancer pleiotropic associations with lung cancer risk in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 20. pii: 1055-9965.EPI-18-0935.
    PubMed     Abstract available
    
    
    
29. MAGUIRE FB, Morris CR, Parikh-Patel A, Cress RD, et al
    Disparities in systemic treatment use in advanced-stage non-small cell lung cancer by source of health insurance.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0823.
    PubMed     Abstract available
    
    
    February 2019
30. PALAZZO LL, Sheehan DF, Tramontano AC, Kong CY, et al
    Disparities and Trends in Rates of Genetic Testing and Erlotinib Treatment Among Metastatic Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 20. pii: 1055-9965.EPI-18-0917.
    PubMed     Abstract available
    
    
    
31. PETERS BA, Hayes RB, Goparaju C, Reid C, et al
    The microbiome in lung cancer tissue and recurrence-free survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0966.
    PubMed     Abstract available
    
    
    January 2019
32. ZHU Y, Wei Y, Zhang R, Dong X, et al
    Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0356.
    PubMed     Abstract available
    
    
    
33. LUSK CM, Wenzlaff AS, Watza D, Sieren JC, et al
    Quantitative imaging markers of lung function in a smoking population distinguish COPD sub-groups with differential lung cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0886.
    PubMed     Abstract available
    
    
    October 2018
34. NIU Y, Su M, Wu Y, Fu L, et al
    Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0723.
    PubMed     Abstract available
    
    
    
35. BROWN D, Zingone A, Yu Y, Zhu B, et al
    Relationship between circulating inflammation proteins and lung cancer diagnosis in the National Lung Screening Trial.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 8. pii: 1055-9965.EPI-18-0598.
    PubMed     Abstract available
    
    
    September 2018
36. GUO Y, Zhang R, Shen S, Wei Y, et al
    DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 5. pii: 1055-9965.EPI-18-0454.
    PubMed     Abstract available
    
    
    August 2018
37. ERICKSON P, Gardner LD, Loffredo CA, St George DM, et al
    Racial and Ethnic Differences in the Relationship Between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 31. pii: 1055-9965.EPI-18-0366.
    PubMed     Abstract available
    
    
    May 2018
38. DOHERTY JA, Grieshober L, Houck JR, Barnett MJ, et al
    Telomere length and lung cancer mortality among heavy smokers.
    Cancer Epidemiol Biomarkers Prev. 2018 May 9. pii: 1055-9965.EPI-17-1183.
    PubMed     Abstract available
    
    
    March 2018
39. ROSS K, Kramer MR, Jemal A
    Geographic Inequalities in Progress against Lung Cancer among Women in the United States, 1990-2015.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 30. pii: 1055-9965.EPI-17-0934.
    PubMed     Abstract available
    
    
    
40. LIN J, Kamamia C, Brown D, Shao S, et al
    Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER population.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 12. pii: 1055-9965.EPI-17-0822.
    PubMed     Abstract available
    
    
    January 2018
41. ZHAO Y, Varn FS, Cai G, Xiao F, et al
    A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2018;27:86-95.
    PubMed     Abstract available
    
    
    October 2017
42. LUND JL, Sanoff HK, Peacock-Hinton S, Muss H, et al
    Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 4. pii: cebp.0523.2017.
    PubMed     Abstract available
    
    
    July 2017
43. ARGIRION I, Weinstein SJ, Mannisto S, Albanes D, et al
    Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11. pii: cebp.0293.2017.
    PubMed     Abstract available
    
    
    June 2017
44. JONES CC, Bush WS, Crawford DC, Wenzlaff AS, et al
    Germline genetic variants and lung cancer survival in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 15. pii: cebp.0998.2016.
    PubMed     Abstract available
    
    
    
45. BOSSE Y, Amos CI
    A decade of GWAS results in lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 14. pii: cebp.0794.2016.
    PubMed     Abstract available
    
    
    April 2017
46. BOFFA DJ, Graf RP, Salazar MC, Hoag J, et al
    Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.
    Cancer Epidemiol Biomarkers Prev. 2017 Apr 26. pii: cebp.0120.2017.
    PubMed     Abstract available
    
    
    
47. TORRE LA, Islami F, Siegel RL, Ward EM, et al
    Global Cancer in Women: Burden and Trends.
    Cancer Epidemiol Biomarkers Prev. 2017;26:444-457.
    PubMed     Abstract available
    
    
    March 2017
48. BOSSE Y, Sazonova O, Gaudreault N, Bastien N, et al
    Transcriptomic Microenvironment of Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2017;26:389-396.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: